Viewing Study NCT04065269


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-01-04 @ 9:47 AM
Study NCT ID: NCT04065269
Status: RECRUITING
Last Update Posted: 2024-07-11
First Post: 2019-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss
Sponsor: Institute of Cancer Research, United Kingdom
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module